These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 28496443)

  • 21. The Delay of Diagnosis in Spondyloarthropathy Patients in a Tertiary Hospital in Saudi Arabia.
    Bedaiwi MK; Baeshen MO; Bin Zuair A; AlRasheed RF
    Cureus; 2021 Jan; 13(1):e12629. PubMed ID: 33447495
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CRP and ASDAS are associated with future elevated arterial stiffness, a risk marker of cardiovascular disease, in patients with ankylosing spondylitis: results after 5-year follow-up.
    Berg IJ; Semb AG; van der Heijde D; Kvien TK; Olsen IC; Dagfinrud H; Provan SA
    Ann Rheum Dis; 2015 Aug; 74(8):1562-6. PubMed ID: 25795906
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Validity of Simplified Ankylosing Spondylitis Disease Activity Scores (SASDAS) in Indian Ankylosing Spondylitis Patients.
    Bansal N; Duggal L; Jain N
    J Clin Diagn Res; 2017 Sep; 11(9):OC06-OC09. PubMed ID: 29207750
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A patient-reported outcome measures-based composite index (RAPID3) for the assessment of disease activity in ankylosing spondylitis.
    Cinar M; Yilmaz S; Cinar FI; Koca SS; Erdem H; Pay S; Dinc A; Yazici Y; Simsek I
    Rheumatol Int; 2015 Sep; 35(9):1575-80. PubMed ID: 25794571
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Validation of disease activity and functional status questionnaires in spondyloarthritis.
    Quinzanos I; Luong PT; Bobba S; Steuart Richards J; Majithia V; Davis LA; Caplan L
    Clin Exp Rheumatol; 2015; 33(2):146-52. PubMed ID: 25664820
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ASDAS high disease activity versus BASDAI elevation in patients with ankylosing spondylitis as selection criterion for anti-TNF therapy.
    Vastesaeger N; Cruyssen BV; Mulero J; Gratacós Masmitjá J; Zarco P; Almodovar R; Font P; Juanola X; Collantes-Estevez E;
    Reumatol Clin; 2014; 10(4):204-9. PubMed ID: 24598027
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Gender difference in clinical manifestations and comorbidities in the patients with spondyloarthritis].
    Wen YQ; Jiang YT; Liu ZY; Huang CH; Chen QY; Chen HS; Pan YF; Gu JR
    Zhonghua Yi Xue Za Zhi; 2019 Mar; 99(11):812-817. PubMed ID: 30893722
    [No Abstract]   [Full Text] [Related]  

  • 28. The Prevalence of Renal Impairment in Patients with Spondyloarthritis: Results from the International ASAS-COMOSPA Study.
    Couderc M; Pereira B; Molto A; Tiple A; Soubrier M; Dougados M
    J Rheumatol; 2018 Jun; 45(6):795-801. PubMed ID: 29657148
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of spondylarthritis activity by patients and physicians: ASDAS, BASDAI, PASS, and flares in 200 patients.
    Godfrin-Valnet M; Prati C; Puyraveau M; Toussirot E; Letho-Gyselink H; Wendling D
    Joint Bone Spine; 2013 Jul; 80(4):393-8. PubMed ID: 23453478
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-agalactosyl IgG antibody in ankylosing spondylitis and psoriatic arthritis.
    Chou CL; Wu MJ; Yu CL; Lu MC; Hsieh SC; Wu TH; Chou CT; Tsai CY
    Clin Rheumatol; 2010 Aug; 29(8):875-81. PubMed ID: 20229261
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Achievement rate and predictive factors of the recommended therapeutical target in patients with axial spondyloarthritis who remain on biological therapy: a prospective cohort study in Spain.
    Benavent D; Franco-Gómez K; Plasencia-Rodriguez C; Novella-Navarro M; Bogas P; Nieto R; Monjo I; Nuño L; Villalba A; Peiteado D; Balsa A; Navarro-Compán V
    BMJ Open; 2022 Apr; 12(4):e057850. PubMed ID: 35487753
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Both ASDAS and ADC are associated with spinal mobility in active axial spondyloarthritis: A comparison between early and later disease.
    Chung HY; Chan SCW; Lee KH; Tsang HHL; Ng LL; Lau CS
    Int J Rheum Dis; 2022 Mar; 25(3):317-326. PubMed ID: 35019230
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decreased plasma vitamin D levels in patients with undifferentiated spondyloarthritis and ankylosing spondylitis.
    Erten S; Kucuksahin O; Sahin A; Altunoglu A; Akyol M; Koca C
    Intern Med; 2013; 52(3):339-44. PubMed ID: 23370741
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ASDAS is associated with both the extent and intensity of DW-MRI spinal inflammation in active axial spondyloarthritis.
    Chung HY; Chui ETF; Lee KH; Tsang HHL; Chan SCW; Lau CS
    RMD Open; 2019; 5(2):e001008. PubMed ID: 31452930
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A study on calculating the ankylosing spondylitis disease activity score according to the C-reactive protein level].
    Ji X; Du J; Zhu J; Huang F; Zhang J
    Zhonghua Nei Ke Za Zhi; 2016 Mar; 55(3):206-10. PubMed ID: 26926373
    [TBL] [Abstract][Full Text] [Related]  

  • 36. How to calculate the ASDAS based on C-reactive protein without individual questions from the BASDAI: the BASDAI-based ASDAS formula.
    Aranda-Valera IC; Garrido-Castro JL; Ladehesa-Pineda L; Vazquez-Mellado J; Zarco P; Juanola X; Gonzalez-Navas C; Font-Ugalde P; Castro-Villegas MC
    Rheumatology (Oxford); 2020 Jul; 59(7):1545-1549. PubMed ID: 31628804
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ASDAS, BASDAI and different treatment responses and their relation to biomarkers of inflammation, cartilage and bone turnover in patients with axial spondyloarthritis treated with TNFα inhibitors.
    Pedersen SJ; Sørensen IJ; Garnero P; Johansen JS; Madsen OR; Tvede N; Hansen MS; Thamsborg G; Andersen LS; Majgaard O; Loft AG; Erlendsson J; Asmussen K; Jurik AG; Møller J; Hasselquist M; Mikkelsen D; Skjødt T; Lambert R; Hansen A; Østergaard M
    Ann Rheum Dis; 2011 Aug; 70(8):1375-81. PubMed ID: 21551511
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thrombin generation in ankylosing spondylitis.
    Prati C; Racadot E; Cedoz JP; Wendling D
    Clin Rheumatol; 2011 Apr; 30(4):511-4. PubMed ID: 20714763
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum and synovial fluid levels of p40 IL12/23 in spondyloarthropathy patients.
    Wendling D; Cedoz JP; Racadot E
    Clin Rheumatol; 2009 Feb; 28(2):187-90. PubMed ID: 18827961
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of ASDAS and BASDAI as a measure of disease activity in axial psoriatic arthritis.
    Kılıç G; Kılıç E; Nas K; Karkucak M; Çapkın E; Dağlı AZ; Çevik R; Özgöçmen S
    Clin Rheumatol; 2015 Mar; 34(3):515-21. PubMed ID: 24985042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.